nimustine has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosono, J; Kawamata, T; Komori, T; Maruyama, T; Masui, K; Muragaki, Y; Nitta, M; Saito, T; Yokoo, H | 1 |
| Bandoh, S; Fujita, M; Funamoto, Y; Kuwabara, H; Nagai, M; Takahara, J; Tasaka, T; Yamaoka, G; Yamauchi, A | 1 |
2 other study(ies) available for nimustine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Cell Transformation, Neoplastic; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p15; Cytoreduction Surgical Procedures; DNA Mutational Analysis; DNA, Neoplasm; Female; Gene Deletion; Genes, p16; Humans; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Nimustine; Photochemotherapy; Porphyrins; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Radiosurgery; Reoperation; Telomerase; Temporal Lobe | 2019 |
Secondary myeloid/natural killer cell precursor acute leukemia following essential thrombocythemia.
Topics: Antigens, CD; Cell Transformation, Neoplastic; Humans; Immunophenotyping; Killer Cells, Natural; Leukemia, Myeloid; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Thrombocythemia, Essential | 1999 |